Table 6:
Relationship Between OxyContin Misuse and Changes in Overall Overdose Death Rates
| Outcome: | Overdose Deaths per 100,000 |
|||||
|---|---|---|---|---|---|---|
| (1) | (2) | (3) | (4) | (5) | (6) | |
| A. Opioid and Heroin Deaths | ||||||
| Initial OxyContin (3 Year Effect) | 0.362 (2.385) | 1.802 (2.060) | 1.429 (2.148) | 3.483 (2.129) | 0.257 (0.214) | 0.378* (0.225) |
| Initial Pain Reliever (3 Year Effect) | −0.947* (0.475) | −0.123** (0.053) | ||||
| Mean of Dep. Variable (2008–09): | 6.068 | |||||
| B. All Overdoses | ||||||
| Initial OxyContin (3 Year Effect) | 0.205 (2.974) | 2.353 (3.064) | 1.322 (2.824) | 3.713 (2.914) | 0.041 (0.157) | 0.123 (0.169) |
| Initial Pain Reliever (3 Year Effect) | −1.017* (0.602) | −0.078* (0.047) | ||||
| Mean of Dep. Variable (2008–09): | 13.097 | |||||
| State and Time-Varying Covariates | No | Yes | Yes | Yes | Yes | Yes |
| Policy Variables | No | No | Yes | Yes | Yes | Yes |
| Estimator | OLS | OLS | OLS | OLS | Poisson | Poisson |
Notes: Standard errors in parentheses adjusted for clustering at the state-level. State fixed effects and year fixed effects included in all specifications. Each model also includes a linear trend interacted with initial nonmedical OxyContin misuse as well as a post-2011 indicator interacted with initial nonmedical OxyContin misuse. Finally, a separate post-2011 linear trend interacted with initial nonmedical OxyContin misuse is also included. We report the 3 year post-2011 effect of the initial OxyContin variable. Regressions are weighted by population. Years 2008–2013 are used.
Significant at the 1% level
Significant at the 5% level
Significant at the 10% level.